Press center

"Biotherapies and Bioproduction of Innovative Therapies" acceleration strategy: the R&D consortium led by Cell-Easy obtained public funding. Read more...

The group accelerates its pharmaceutical business expansion in the Americas to consolidate its global leadership position and reinforce its commitment to customer-focused innovation.

Unlock nature’s potential with LYCAGEL® PREMIX – a new easy-to-use plant-based softgel blend for nutraceutical and pharmaceutical applications.

The e-commerce platform will provide users with access to Roquette’s trusted and reliable flagship pharmaceutical and biopharmaceutical offering at smaller quantities for the first time.

This new vegetarian softgel capsule is based on Roquette’s LYCAGEL™ pea starch softgel technology.